Innospec Inc. Files 8-K on Financials

Ticker: IOSP · Form: 8-K · Filed: May 10, 2024 · CIK: 1054905

Sentiment: neutral

Topics: financial-condition, results-of-operations, regulation-fd

TL;DR

Innospec dropped an 8-K on May 9th detailing financials and operations.

AI Summary

Innospec Inc. filed an 8-K on May 10, 2024, reporting on its results of operations and financial condition as of May 9, 2024. The filing also included Regulation FD disclosures and financial statements/exhibits. The company, formerly known as Octel Corp, is incorporated in Delaware and headquartered in Englewood, Colorado.

Why It Matters

This 8-K filing provides investors with crucial updates on Innospec's financial performance and operational status, enabling informed investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Innospec Inc.'s results of operations and financial condition, as well as to provide Regulation FD disclosures and financial statements and exhibits.

On what date is the earliest event reported in this filing?

The earliest event reported in this filing is dated May 9, 2024.

What is Innospec Inc.'s state of incorporation?

Innospec Inc. is incorporated in Delaware.

What was Innospec Inc.'s former company name?

Innospec Inc.'s former company name was OCTEL CORP.

Where are Innospec Inc.'s principal executive offices located?

Innospec Inc.'s principal executive offices are located at 8310 South Valley Highway, Suite 350, Englewood, Colorado, 80112.

Filing Stats: 484 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-05-10 06:07:02

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. EXHIBIT INDEX Number Description Method of Filing 99.1 Press Release dated May 9, 2024 announcing Innospec Inc.'s financial results for the fiscal quarter ended March 31, 2024 Filed Herewith 104 Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INNOSPEC INC. Date: May 10, 2024 By: /s/ David B. Jones David B. Jones Senior Vice President, General Counsel and Chief Compliance Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing